JOHN PATIENCE
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
PAUL BERESFORD, PH.D., WENDY BLOSSER, DAVID BRUNEL, ROBERT CAWTHORN, BOBBI COFFIN, ROBIN COWIE, LIZ FLIEGELMAN, JEAN FRANCHI, ROBERT GEORGANTAS, SCOTT HUTTON, HANY MASSARANY, MARK MILLER, GARY PESTANO, PH.D., JIM PURVIS, HEINRICH RODER, HEINRICH RODER, D.PHIL, HEINRICH RODER, D.PHIL., FRANK RONCHETTI, JACK SCHULER, MATT STAUFFER, MATTHEW STROBECK, LINDA TRAYLOR, PH.D., CHARLES WATTS
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DIRECTOR
PETE BANTOCK, THOMAS D. BROWN, WAYNE C. BURRIS, ROLAND DIGGELMANN, LOUISE L. FRANCESCONI, THOMAS GEIMER, THOMAS V. GEIMER, CHARLES E. GERRETSON, DAVID C. HOWSON, ROMNEY HUMPHRIES, JOHN D. KUCERA, HANY MASSARANY, LAWRENCE MEHREN, MARK C. MILLER, JOHN J. PHILLIPS, RON PRICE, STEVE REICHLING, JACK SCHULER, MATHEW W STROBECK, MATTHEW STROBECK, MATTHEW W. STROBECK, MATTHEW W. STROBECK, PH.D, FRANK J.M. TEN BRINK, CHARLES WATTS
DIRECTOR
PETE BANTOCK, THOMAS D. BROWN, WAYNE C. BURRIS, ROLAND DIGGELMANN, LOUISE L. FRANCESCONI, THOMAS GEIMER, THOMAS V. GEIMER, CHARLES E. GERRETSON, DAVID C. HOWSON, ROMNEY HUMPHRIES, JOHN D. KUCERA, HANY MASSARANY, LAWRENCE MEHREN, MARK C. MILLER, JOHN J. PHILLIPS, RON PRICE, STEVE REICHLING, JACK SCHULER, MATHEW W STROBECK, MATTHEW STROBECK, MATTHEW W. STROBECK, MATTHEW W. STROBECK, PH.D, FRANK J.M. TEN BRINK, CHARLES WATTS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2022-03-24
D/A
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2020-12-24
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2021-09-22
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2020-12-24
D/A
BIOTECHNOLOGY
SERVICES-MEDICAL LABORATORIES [8071]
DECLINE TO DISCLOSE
2019-12-10
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2019-08-20
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2014-05-19
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$1 - $1,000,000
Equity
2013-08-14
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$1,000,001 - $5,000,000
Equity
2012-06-26

